On June 30, 2017, Envision Healthcare Corporation (the Company)
announced that all outstanding shares of its 5.250% Mandatory
Convertible Preferred Stock, Series A1 (the Preferred Stock) will
automatically convert into shares of the Companys common stock,
$0.01 par value (the Common Stock), to the terms of the Preferred
Stock as set forth in the Companys Second Amended and Restated
Certificate of Incorporation. The conversion will be effective at
5:00 p.m. eastern daylight savings time on July 3, 2017
(Mandatory Conversion Date), which is the first business day
following the conversion date of July 1, 2017. No action by
holders of Preferred Stock is required in connection with the
mandatory conversion.

On the Mandatory Conversion Date, each share of Preferred Stock,
unless previously converted, will automatically convert into
1.8141 shares of Common Stock. The number of shares of Common
Stock issuable on conversion was determined based on the volume
weighted average price per share of the Common Stock over the
20-trading-day period ending on June 29, 2017, in accordance with
the terms of the Preferred Stock. The Company will pay cash in
lieu of any fractional share upon conversion.

As previously announced, the next scheduled dividend payment date
with respect to the Preferred Stock is the Mandatory Conversion
Date, payable to record holders of the Preferred Stock as of June
15, 2017 in the customary manner.

Following the Mandatory Conversion Date, shares of Preferred
Stock will no longer be outstanding and all rights of the holders
with respect to such Preferred Stock, including dividend rights,
will terminate, except for the right to receive the number of
whole shares of Common Stock issuable upon conversion of the
Preferred Stock and cash in lieu of any fractional shares of
Common Stock, as described above. Upon conversion, the Preferred
Stock will be delisted from trading on the New York Stock
Exchange.

As of March 31, 2017, the Company had outstanding 1,725,000
shares of Preferred Stock, all of which will be converted to
Common Stock on or before the Mandatory Conversion Date. The
impact of this conversion was contemplated in the Companys
previously issued adjusted net earnings per share guidance, which
gives effect to the dilutive impact of the conversion.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.